“Intestinal-type” mucinous adenocarcinoma of the vulva: a report of two cases

Background: "Intestinal-type" mucinous carcinoma of the vulva is extremely rare with very few cases reported in the literature. Case report: The authors report two patients who had diagnosis of intestinal-type mucinous adenocarcinoma of the vulva after excisional biopsy. In both cases, restaging was perfomed with total body computed tomography (CT) scan, gastroscopy, and colonoscopy that showed no other site of disease. A radical vulvectomy with bilateral systematic inguinal lymphadenectomy was performed, and in both cases no residual disease was found. A patient developed metastatic (liver, bone marrow) colonic cancer 36 months after primary surgery, received multiple lines of chemotherapy, and died of disseminated disease 18 months after diagnosis. The other patient was found to have dysplastic polyp in the sigmoid colon, and is alive without disease at 39 months after primary diagnosis. Conclusion: Intestinal-type mucinous carcinoma of the vulva has a poor prognosis. Strict endoscopic follow-up of the colon is mandatory in such cases, considering the high propensity of associated gastrointestinal (GI) tumors.

Adenocarcinoma of the vulva; Intestinal-type

[1] Ghamande S.A., Kasznica J., Griffiths T., Finkler N.J., Hamid A.M.: “Mucinous adenocarcinomas of the vulva”. Gynecol. Oncol., 1995, 57, 117.

[2] Kennedy J.C., Majmudar B.: “Primary adenocarcinoma of the vulva, possibly cloacogenic. A report of two cases”. J. Reprod. Med., 1993, 38, 113.

[3] Nasir S., Zaidi H., Conner M.C.: “Primary vulvar adenocarcinoma of cloacogenic origin”. South Med. J., 2001, 94, 744.

[4] Tiltman A.J., Knutzen V.K.: “Primary adenocarcinoma of the vulva originating in misplaced cloacal tissue”. Obstet. Gynecol., 1978, 51, 30s.

[5] Wille´n R., Be´ka´ssy Z., Carle´n B., Bozoky B., Cajander S.: “Cloacogenic adenocarcinoma of the vulva”. Gynecol. Oncol., 1999, 74, 298.

[6] Wilkinson E.J.: “Premalignant and malignant tumors of the vulva”. In: Kurman R.J. (ed.): Blaustein’s Pathology of the Female Genital Tract. 5th edition. New York, Springer-Verlag, 2002, 122.

[7] Rodriguez A., Isaac M.A., Hidalgo E., Marquez B., Nogales F.F.: “Villoglandular adenocarcinoma of the vulva”. Gynecol. Oncol., 2001, 83, 409.

[8] Frierson H.F., Mills S.E.: “The vulva and vagina”. In: Sternberg S.S., Antonioli D.A., Carter D. et al. (eds.), Diagnostic Surgical Pathology, 3rd edition. Philadelphia, Lippincott Williams and Wilkins, 1999, 2129.

[9] Novak E.R., Woodruff J.D.: “Gynecologic and Obstetric Pathology With Clinical and Endocrine Relations”. 7th edition. Philadelphia, Saunders, 1974, 26.

[10] Loy T.S., Caladuce R.D., Keeney G.L.: “Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma”. Mod. Pathol., 1996, 9, 1040.

[11] Dube V., Veilleux C., Plante M., Tetu B.: “Primary villoglandular adenocarcinoma of cloacogenic origin of the vulva”. Hum. Pathol., 2004, 35, 377.

[12] Hsu S.M., Raine L., Fanger H.: “Use of avidin-biotin-peroxydase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures”. J. Histochem. Cytochem, 1981, 29, 577.